Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Transesophageal | 66 | 2023 | 1133 | 7.270 |
Why?
|
Echocardiography, Three-Dimensional | 33 | 2023 | 591 | 4.610 |
Why?
|
Anesthesiology | 18 | 2024 | 1060 | 4.290 |
Why?
|
Monitoring, Intraoperative | 19 | 2019 | 957 | 2.940 |
Why?
|
Clinical Competence | 24 | 2023 | 4687 | 2.560 |
Why?
|
Echocardiography | 26 | 2023 | 5099 | 2.330 |
Why?
|
Ultrasonography, Interventional | 12 | 2023 | 1486 | 2.230 |
Why?
|
Models, Anatomic | 7 | 2023 | 691 | 2.210 |
Why?
|
Cardiopulmonary Bypass | 6 | 2020 | 1066 | 2.110 |
Why?
|
Atrial Appendage | 8 | 2020 | 283 | 2.100 |
Why?
|
Neuropeptide Y | 5 | 2020 | 200 | 2.080 |
Why?
|
Nerve Block | 7 | 2021 | 644 | 2.010 |
Why?
|
Perioperative Care | 12 | 2018 | 1002 | 2.000 |
Why?
|
Ultrasonography | 20 | 2023 | 5984 | 1.910 |
Why?
|
Anesthesia, General | 8 | 2022 | 1171 | 1.830 |
Why?
|
Internship and Residency | 18 | 2023 | 5791 | 1.660 |
Why?
|
Aortic Aneurysm, Abdominal | 10 | 2023 | 1186 | 1.640 |
Why?
|
Catheterization, Central Venous | 5 | 2022 | 514 | 1.610 |
Why?
|
Mitral Valve Insufficiency | 17 | 2021 | 1421 | 1.550 |
Why?
|
Mitral Valve | 24 | 2021 | 1491 | 1.530 |
Why?
|
Vascular Surgical Procedures | 11 | 2014 | 1476 | 1.490 |
Why?
|
Manikins | 7 | 2023 | 238 | 1.430 |
Why?
|
Cardiac Surgical Procedures | 18 | 2023 | 3537 | 1.360 |
Why?
|
Heart Diseases | 10 | 2021 | 2789 | 1.340 |
Why?
|
Echocardiography, Doppler | 6 | 2018 | 935 | 1.330 |
Why?
|
Anesthesia, Conduction | 2 | 2022 | 238 | 1.330 |
Why?
|
Myocardial Ischemia | 9 | 2020 | 2148 | 1.310 |
Why?
|
Pain, Postoperative | 4 | 2021 | 1643 | 1.310 |
Why?
|
Coronary Artery Bypass | 12 | 2022 | 2288 | 1.310 |
Why?
|
Oxidative Stress | 6 | 2020 | 3084 | 1.220 |
Why?
|
Catheterization, Peripheral | 3 | 2020 | 345 | 1.180 |
Why?
|
Point-of-Care Systems | 7 | 2023 | 1178 | 1.140 |
Why?
|
Lower Extremity | 5 | 2022 | 1158 | 1.140 |
Why?
|
Anesthesia | 6 | 2022 | 1561 | 1.090 |
Why?
|
Tricuspid Valve Insufficiency | 8 | 2021 | 349 | 1.060 |
Why?
|
Mitral Valve Annuloplasty | 5 | 2021 | 143 | 1.020 |
Why?
|
Myocardial Revascularization | 3 | 2019 | 841 | 1.000 |
Why?
|
Ventricular Outflow Obstruction | 3 | 2019 | 272 | 1.000 |
Why?
|
Diastole | 8 | 2012 | 791 | 1.000 |
Why?
|
Intraoperative Complications | 4 | 2019 | 1198 | 0.990 |
Why?
|
Workflow | 3 | 2020 | 847 | 0.990 |
Why?
|
Myocardium | 6 | 2020 | 4772 | 0.980 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2017 | 282 | 0.980 |
Why?
|
Drainage | 2 | 2020 | 1142 | 0.970 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2023 | 1391 | 0.970 |
Why?
|
Anesthesia, Epidural | 2 | 2016 | 228 | 0.970 |
Why?
|
Preoperative Care | 5 | 2019 | 2251 | 0.960 |
Why?
|
Ischemia | 5 | 2017 | 1907 | 0.960 |
Why?
|
Echocardiography, Doppler, Color | 10 | 2019 | 364 | 0.960 |
Why?
|
Education, Medical, Graduate | 6 | 2022 | 2291 | 0.950 |
Why?
|
Hypotension | 2 | 2021 | 884 | 0.920 |
Why?
|
Educational Measurement | 4 | 2021 | 1210 | 0.900 |
Why?
|
Thoracic Vertebrae | 2 | 2018 | 608 | 0.900 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2020 | 581 | 0.870 |
Why?
|
Tricuspid Valve | 8 | 2021 | 403 | 0.850 |
Why?
|
Heart Atria | 7 | 2019 | 1356 | 0.820 |
Why?
|
Postoperative Complications | 15 | 2023 | 15297 | 0.800 |
Why?
|
Motion | 2 | 2016 | 798 | 0.790 |
Why?
|
Cardiology | 3 | 2018 | 1668 | 0.780 |
Why?
|
Aortic Valve Stenosis | 9 | 2018 | 1965 | 0.770 |
Why?
|
Humans | 182 | 2024 | 744366 | 0.770 |
Why?
|
Hemodynamics | 10 | 2020 | 4196 | 0.750 |
Why?
|
Benzyl Alcohols | 1 | 2020 | 29 | 0.740 |
Why?
|
Heart Valve Prosthesis Implantation | 11 | 2020 | 1537 | 0.740 |
Why?
|
Factor VII Deficiency | 1 | 2019 | 32 | 0.720 |
Why?
|
Computer Simulation | 10 | 2023 | 6194 | 0.720 |
Why?
|
Computer-Assisted Instruction | 2 | 2014 | 365 | 0.720 |
Why?
|
Oxalates | 1 | 2020 | 105 | 0.720 |
Why?
|
Ventricular Function, Right | 4 | 2020 | 591 | 0.710 |
Why?
|
Paraplegia | 1 | 2020 | 169 | 0.700 |
Why?
|
Thoracic Surgery, Video-Assisted | 3 | 2021 | 273 | 0.700 |
Why?
|
Nurse Anesthetists | 1 | 2019 | 18 | 0.700 |
Why?
|
Pericardiocentesis | 1 | 2019 | 74 | 0.690 |
Why?
|
Anesthesia Recovery Period | 1 | 2020 | 157 | 0.690 |
Why?
|
Spinal Cord Ischemia | 1 | 2020 | 94 | 0.680 |
Why?
|
RNA | 2 | 2020 | 2749 | 0.680 |
Why?
|
Thrombosis | 5 | 2014 | 2968 | 0.670 |
Why?
|
Spinal Nerve Roots | 1 | 2019 | 121 | 0.660 |
Why?
|
Ventricular Dysfunction | 1 | 2019 | 143 | 0.650 |
Why?
|
Atrial Fibrillation | 8 | 2020 | 5035 | 0.640 |
Why?
|
Receptors, Neuropeptide Y | 3 | 2016 | 44 | 0.640 |
Why?
|
Aged | 66 | 2022 | 163288 | 0.630 |
Why?
|
Aorta | 3 | 2017 | 2062 | 0.630 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 253 | 0.630 |
Why?
|
Thrombelastography | 1 | 2019 | 164 | 0.630 |
Why?
|
Curriculum | 8 | 2023 | 3605 | 0.600 |
Why?
|
Prosthesis Design | 4 | 2018 | 2110 | 0.590 |
Why?
|
Nanoparticles | 2 | 2020 | 1905 | 0.590 |
Why?
|
Cardiotonic Agents | 1 | 2020 | 535 | 0.580 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2012 | 2073 | 0.580 |
Why?
|
Pneumothorax | 2 | 2017 | 379 | 0.570 |
Why?
|
Leukocytosis | 1 | 2017 | 247 | 0.550 |
Why?
|
Jugular Veins | 1 | 2017 | 204 | 0.540 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1151 | 0.540 |
Why?
|
Male | 83 | 2022 | 350115 | 0.540 |
Why?
|
Certification | 1 | 2019 | 423 | 0.540 |
Why?
|
Ventricular Function, Left | 4 | 2020 | 3666 | 0.540 |
Why?
|
Thoracic Surgical Procedures | 1 | 2019 | 342 | 0.530 |
Why?
|
Mitochondria, Heart | 1 | 2017 | 247 | 0.530 |
Why?
|
Neovascularization, Physiologic | 2 | 2020 | 1351 | 0.520 |
Why?
|
Myocardial Infarction | 7 | 2022 | 11718 | 0.520 |
Why?
|
Bronchoscopy | 1 | 2021 | 862 | 0.520 |
Why?
|
Body Surface Area | 2 | 2014 | 199 | 0.510 |
Why?
|
Hindlimb | 1 | 2017 | 504 | 0.510 |
Why?
|
Endovascular Procedures | 5 | 2023 | 1980 | 0.510 |
Why?
|
Aorta, Thoracic | 2 | 2019 | 1084 | 0.510 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2016 | 125 | 0.500 |
Why?
|
Hand | 3 | 2023 | 884 | 0.500 |
Why?
|
Heart Ventricles | 10 | 2019 | 3817 | 0.500 |
Why?
|
Ulnar Artery | 1 | 2014 | 17 | 0.500 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2016 | 235 | 0.480 |
Why?
|
Aortic Diseases | 1 | 2020 | 743 | 0.480 |
Why?
|
Analgesia | 1 | 2019 | 461 | 0.480 |
Why?
|
Heart Aneurysm | 2 | 2012 | 120 | 0.480 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2015 | 95 | 0.480 |
Why?
|
Analgesia, Epidural | 1 | 2017 | 326 | 0.470 |
Why?
|
Intraoperative Care | 4 | 2019 | 767 | 0.470 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1199 | 0.470 |
Why?
|
Perioperative Period | 2 | 2014 | 256 | 0.470 |
Why?
|
Shock, Cardiogenic | 1 | 2019 | 688 | 0.470 |
Why?
|
Female | 73 | 2022 | 380193 | 0.460 |
Why?
|
Ventricular Septal Rupture | 1 | 2013 | 18 | 0.460 |
Why?
|
Infection Control | 1 | 2021 | 965 | 0.460 |
Why?
|
Mitral Valve Prolapse | 1 | 2015 | 231 | 0.450 |
Why?
|
Blood Vessel Prosthesis | 1 | 2018 | 934 | 0.450 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1525 | 0.450 |
Why?
|
Heart Septal Defects, Atrial | 2 | 2015 | 478 | 0.450 |
Why?
|
Myocardial Contraction | 3 | 2020 | 1579 | 0.450 |
Why?
|
Spinal Stenosis | 1 | 2016 | 255 | 0.450 |
Why?
|
Lung Diseases | 2 | 2021 | 1887 | 0.450 |
Why?
|
Polymers | 1 | 2020 | 1621 | 0.440 |
Why?
|
Peripheral Arterial Disease | 2 | 2021 | 1188 | 0.420 |
Why?
|
Dyspnea | 1 | 2020 | 1303 | 0.420 |
Why?
|
Septal Occluder Device | 1 | 2013 | 128 | 0.420 |
Why?
|
Teaching | 3 | 2014 | 1174 | 0.410 |
Why?
|
Sympathetic Nervous System | 1 | 2014 | 513 | 0.400 |
Why?
|
Middle Aged | 49 | 2021 | 213390 | 0.400 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1178 | 0.400 |
Why?
|
Catheterization | 2 | 2016 | 1470 | 0.400 |
Why?
|
Cardiac Output | 1 | 2014 | 854 | 0.400 |
Why?
|
Heart Valve Prosthesis | 7 | 2021 | 1490 | 0.390 |
Why?
|
Neuropeptides | 1 | 2017 | 942 | 0.390 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 874 | 0.390 |
Why?
|
Up-Regulation | 1 | 2020 | 4222 | 0.380 |
Why?
|
Phantoms, Imaging | 2 | 2019 | 2480 | 0.380 |
Why?
|
Coronary Artery Disease | 5 | 2021 | 6486 | 0.380 |
Why?
|
Prospective Studies | 22 | 2024 | 53290 | 0.380 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5749 | 0.380 |
Why?
|
Heart Valve Diseases | 4 | 2021 | 1074 | 0.380 |
Why?
|
Postoperative Care | 1 | 2017 | 1487 | 0.380 |
Why?
|
Kidney Diseases | 1 | 2022 | 2148 | 0.380 |
Why?
|
Pneumonia | 1 | 2022 | 2133 | 0.380 |
Why?
|
Databases, Factual | 4 | 2021 | 7730 | 0.370 |
Why?
|
Faculty, Medical | 1 | 2018 | 1181 | 0.360 |
Why?
|
Retrospective Studies | 24 | 2023 | 77460 | 0.360 |
Why?
|
Aneurysm, False | 3 | 2020 | 276 | 0.350 |
Why?
|
Coronary Thrombosis | 1 | 2012 | 495 | 0.340 |
Why?
|
Treatment Outcome | 21 | 2023 | 63107 | 0.340 |
Why?
|
Radial Artery | 2 | 2020 | 194 | 0.330 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1848 | 0.330 |
Why?
|
Atrial Septum | 3 | 2021 | 60 | 0.330 |
Why?
|
Blood Transfusion | 3 | 2022 | 1301 | 0.330 |
Why?
|
Aorta, Abdominal | 1 | 2011 | 646 | 0.330 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 12073 | 0.320 |
Why?
|
Cardiovascular System | 1 | 2016 | 831 | 0.320 |
Why?
|
Pneumonectomy | 2 | 2016 | 1094 | 0.320 |
Why?
|
Aged, 80 and over | 23 | 2021 | 57776 | 0.320 |
Why?
|
Heart Valves | 2 | 2021 | 291 | 0.320 |
Why?
|
Lipoproteins | 2 | 2005 | 878 | 0.310 |
Why?
|
Tachycardia, Supraventricular | 1 | 2010 | 263 | 0.310 |
Why?
|
Liver Transplantation | 1 | 2019 | 2119 | 0.310 |
Why?
|
User-Computer Interface | 3 | 2012 | 1431 | 0.310 |
Why?
|
Peptide Fragments | 1 | 2020 | 5096 | 0.300 |
Why?
|
Thoracic Surgery | 1 | 2014 | 719 | 0.300 |
Why?
|
Intestines | 1 | 2016 | 1924 | 0.300 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.300 |
Why?
|
Weight Lifting | 1 | 2007 | 131 | 0.300 |
Why?
|
General Surgery | 1 | 2018 | 1636 | 0.290 |
Why?
|
Incidental Findings | 1 | 2012 | 689 | 0.290 |
Why?
|
Apoptosis | 4 | 2020 | 9724 | 0.290 |
Why?
|
Regeneration | 1 | 2016 | 1485 | 0.290 |
Why?
|
Heart Failure | 7 | 2022 | 10895 | 0.280 |
Why?
|
Aortic Rupture | 2 | 2023 | 312 | 0.280 |
Why?
|
Coronary Circulation | 1 | 2012 | 1572 | 0.280 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1240 | 0.270 |
Why?
|
Models, Theoretical | 1 | 2018 | 3589 | 0.270 |
Why?
|
Disease Management | 1 | 2016 | 2460 | 0.270 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2006 | 86 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 12 | 2017 | 8949 | 0.260 |
Why?
|
Immunoblotting | 3 | 2020 | 1683 | 0.260 |
Why?
|
Internet | 2 | 2014 | 3056 | 0.260 |
Why?
|
Sex Factors | 6 | 2022 | 10400 | 0.260 |
Why?
|
Systole | 5 | 2016 | 958 | 0.260 |
Why?
|
Risk Factors | 15 | 2023 | 72296 | 0.250 |
Why?
|
Heart | 4 | 2023 | 4464 | 0.250 |
Why?
|
Time Factors | 11 | 2022 | 40075 | 0.240 |
Why?
|
Drug-Eluting Stents | 1 | 2010 | 753 | 0.230 |
Why?
|
Aortic Valve | 6 | 2013 | 1924 | 0.230 |
Why?
|
Stents | 3 | 2016 | 3282 | 0.230 |
Why?
|
Intraoperative Period | 4 | 2019 | 520 | 0.230 |
Why?
|
Blood Loss, Surgical | 2 | 2017 | 662 | 0.220 |
Why?
|
Military Personnel | 2 | 2023 | 1133 | 0.220 |
Why?
|
Feasibility Studies | 6 | 2020 | 5077 | 0.220 |
Why?
|
Surgical Procedures, Operative | 2 | 2011 | 1877 | 0.210 |
Why?
|
Risk Assessment | 9 | 2021 | 23336 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7282 | 0.210 |
Why?
|
Lung | 1 | 2020 | 9857 | 0.200 |
Why?
|
Thoracotomy | 2 | 2016 | 363 | 0.200 |
Why?
|
DNA | 1 | 2015 | 7294 | 0.190 |
Why?
|
Ventricular Function | 2 | 2013 | 415 | 0.190 |
Why?
|
Heparin | 1 | 2008 | 1637 | 0.190 |
Why?
|
Angioplasty, Balloon | 2 | 2016 | 653 | 0.190 |
Why?
|
Sex Characteristics | 2 | 2008 | 2585 | 0.190 |
Why?
|
Palpation | 1 | 2020 | 167 | 0.190 |
Why?
|
Artificial Intelligence | 4 | 2024 | 2213 | 0.190 |
Why?
|
Predictive Value of Tests | 9 | 2017 | 15078 | 0.190 |
Why?
|
Pulmonary Veins | 2 | 2016 | 761 | 0.180 |
Why?
|
Surgical Wound Infection | 2 | 2022 | 1540 | 0.180 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2008 | 980 | 0.180 |
Why?
|
Logistic Models | 9 | 2017 | 13409 | 0.180 |
Why?
|
Imaging, Three-Dimensional | 4 | 2019 | 4042 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 4 | 2018 | 20130 | 0.180 |
Why?
|
Endoleak | 1 | 2020 | 106 | 0.180 |
Why?
|
Mitral Valve Stenosis | 2 | 2014 | 376 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.180 |
Why?
|
Coronary Vessel Anomalies | 2 | 2014 | 314 | 0.180 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 161 | 0.180 |
Why?
|
Swine | 3 | 2016 | 5918 | 0.180 |
Why?
|
Peripheral Vascular Diseases | 2 | 2014 | 550 | 0.170 |
Why?
|
Benchmarking | 2 | 2023 | 1042 | 0.170 |
Why?
|
Reproducibility of Results | 8 | 2024 | 19905 | 0.170 |
Why?
|
Ulcer | 1 | 2020 | 209 | 0.170 |
Why?
|
Pericardial Effusion | 1 | 2021 | 247 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 11726 | 0.170 |
Why?
|
Immunohistochemistry | 4 | 2017 | 11366 | 0.160 |
Why?
|
Obesity | 2 | 2022 | 12746 | 0.160 |
Why?
|
Intensive Care Units | 2 | 2023 | 3680 | 0.160 |
Why?
|
Pain Measurement | 2 | 2021 | 3420 | 0.160 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18034 | 0.160 |
Why?
|
Fistula | 1 | 2019 | 220 | 0.150 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3070 | 0.150 |
Why?
|
Radiology | 1 | 2012 | 2099 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5223 | 0.150 |
Why?
|
Fibrosis | 2 | 2016 | 2029 | 0.150 |
Why?
|
Diaphragm | 1 | 2019 | 349 | 0.150 |
Why?
|
Motor Skills | 1 | 2020 | 522 | 0.150 |
Why?
|
Medical Errors | 1 | 2006 | 1297 | 0.150 |
Why?
|
Decision Support Techniques | 2 | 2017 | 1956 | 0.150 |
Why?
|
Therapeutics | 1 | 2017 | 116 | 0.150 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2017 | 108 | 0.150 |
Why?
|
Animals | 17 | 2021 | 168768 | 0.140 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.140 |
Why?
|
Ventricular Remodeling | 3 | 2015 | 1223 | 0.140 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2016 | 23 | 0.140 |
Why?
|
Coronary Vessels | 2 | 2016 | 3107 | 0.140 |
Why?
|
Sinus of Valsalva | 1 | 2016 | 59 | 0.130 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.130 |
Why?
|
Perfusion Imaging | 1 | 2017 | 195 | 0.130 |
Why?
|
Bandages | 1 | 2017 | 266 | 0.130 |
Why?
|
Cohort Studies | 6 | 2017 | 40559 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 215 | 0.130 |
Why?
|
Pleura | 1 | 2016 | 235 | 0.130 |
Why?
|
Reoperation | 3 | 2016 | 4201 | 0.130 |
Why?
|
Survival Rate | 2 | 2021 | 12788 | 0.130 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39052 | 0.120 |
Why?
|
Shock, Septic | 1 | 2001 | 775 | 0.120 |
Why?
|
Language | 1 | 2024 | 1471 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1461 | 0.120 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 822 | 0.120 |
Why?
|
Fatal Outcome | 1 | 2019 | 1851 | 0.120 |
Why?
|
Microarray Analysis | 1 | 2017 | 767 | 0.120 |
Why?
|
Physical Examination | 1 | 2020 | 1237 | 0.120 |
Why?
|
Atrial Function, Left | 1 | 2015 | 173 | 0.120 |
Why?
|
Oximetry | 1 | 2017 | 471 | 0.120 |
Why?
|
Coronary Angiography | 4 | 2013 | 4576 | 0.120 |
Why?
|
Severity of Illness Index | 6 | 2015 | 15535 | 0.120 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2014 | 141 | 0.120 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2020 | 691 | 0.120 |
Why?
|
Diverticulum | 1 | 2014 | 136 | 0.120 |
Why?
|
Coronary Sinus | 1 | 2014 | 87 | 0.120 |
Why?
|
Sepsis | 2 | 2005 | 2593 | 0.110 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 432 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2017 | 1588 | 0.110 |
Why?
|
Vena Cava, Superior | 1 | 2014 | 193 | 0.110 |
Why?
|
Caspase 3 | 1 | 2016 | 758 | 0.110 |
Why?
|
Radiography, Interventional | 1 | 2020 | 1095 | 0.110 |
Why?
|
Chronic Disease | 4 | 2013 | 9145 | 0.110 |
Why?
|
Incidence | 4 | 2022 | 20952 | 0.110 |
Why?
|
Anesthetics, Intravenous | 1 | 2016 | 417 | 0.110 |
Why?
|
Glucose Transporter Type 4 | 1 | 2013 | 250 | 0.110 |
Why?
|
Aortic Aneurysm | 1 | 2017 | 644 | 0.110 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 697 | 0.110 |
Why?
|
Femoral Artery | 1 | 2017 | 845 | 0.110 |
Why?
|
Reference Values | 2 | 2017 | 4982 | 0.110 |
Why?
|
Autophagy | 1 | 2020 | 1297 | 0.110 |
Why?
|
Electrocardiography | 3 | 2011 | 6442 | 0.110 |
Why?
|
Algorithms | 3 | 2021 | 13882 | 0.100 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 780 | 0.100 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1641 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13104 | 0.100 |
Why?
|
Chest Pain | 1 | 2019 | 1114 | 0.100 |
Why?
|
Constriction | 1 | 2011 | 181 | 0.100 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 596 | 0.100 |
Why?
|
PPAR gamma | 1 | 2015 | 493 | 0.100 |
Why?
|
Observer Variation | 1 | 2018 | 2593 | 0.100 |
Why?
|
Hypertrophy | 1 | 2013 | 569 | 0.100 |
Why?
|
Focus Groups | 1 | 2016 | 1321 | 0.100 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2011 | 32 | 0.100 |
Why?
|
Pulmonary Artery | 2 | 2012 | 1912 | 0.100 |
Why?
|
Acute Kidney Injury | 2 | 2016 | 1968 | 0.100 |
Why?
|
Intermittent Claudication | 1 | 2013 | 309 | 0.100 |
Why?
|
Body Size | 1 | 2013 | 461 | 0.100 |
Why?
|
Heart Function Tests | 2 | 2010 | 328 | 0.090 |
Why?
|
Recovery of Function | 1 | 2021 | 2926 | 0.090 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1265 | 0.090 |
Why?
|
Catheter Ablation | 2 | 2016 | 2758 | 0.090 |
Why?
|
Ventricular Pressure | 1 | 2011 | 199 | 0.090 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21833 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1206 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 638 | 0.090 |
Why?
|
Stroke | 2 | 2012 | 9981 | 0.090 |
Why?
|
Adult | 13 | 2022 | 214052 | 0.090 |
Why?
|
Software | 6 | 2016 | 4441 | 0.090 |
Why?
|
Punctures | 2 | 2021 | 374 | 0.090 |
Why?
|
Thoracic Injuries | 1 | 2012 | 272 | 0.090 |
Why?
|
Proteins | 1 | 2005 | 6100 | 0.090 |
Why?
|
Patient Simulation | 1 | 2012 | 309 | 0.090 |
Why?
|
Anesthetics, Local | 1 | 2016 | 985 | 0.090 |
Why?
|
Organ Size | 1 | 2014 | 2251 | 0.090 |
Why?
|
Collateral Circulation | 1 | 2010 | 287 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2014 | 1745 | 0.090 |
Why?
|
Postoperative Period | 1 | 2014 | 1842 | 0.080 |
Why?
|
Obstetric Surgical Procedures | 1 | 2008 | 29 | 0.080 |
Why?
|
Blotting, Western | 2 | 2015 | 5181 | 0.080 |
Why?
|
Prognosis | 6 | 2021 | 29060 | 0.080 |
Why?
|
Pulmonary Edema | 1 | 2011 | 414 | 0.080 |
Why?
|
Computer Graphics | 1 | 2010 | 361 | 0.080 |
Why?
|
Ligation | 1 | 2009 | 453 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2760 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2007 | 0.080 |
Why?
|
Adipocytes | 1 | 2015 | 1185 | 0.080 |
Why?
|
Saphenous Vein | 1 | 2011 | 532 | 0.080 |
Why?
|
Operating Rooms | 1 | 2014 | 817 | 0.080 |
Why?
|
Aneurysm | 1 | 2011 | 339 | 0.080 |
Why?
|
Chi-Square Distribution | 4 | 2017 | 3508 | 0.080 |
Why?
|
Psychomotor Performance | 1 | 2016 | 1901 | 0.080 |
Why?
|
Insulin Infusion Systems | 1 | 2009 | 212 | 0.080 |
Why?
|
Age Factors | 3 | 2014 | 18373 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3219 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 35425 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2016 | 1783 | 0.070 |
Why?
|
Analgesics | 1 | 2014 | 1040 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 12961 | 0.070 |
Why?
|
Aortic Valve Insufficiency | 1 | 2011 | 579 | 0.070 |
Why?
|
Interleukin-8 | 2 | 2015 | 690 | 0.070 |
Why?
|
Body Mass Index | 2 | 2022 | 12721 | 0.070 |
Why?
|
Cervical Vertebrae | 1 | 2012 | 976 | 0.070 |
Why?
|
Anticoagulants | 1 | 2001 | 4600 | 0.070 |
Why?
|
Spinal Fractures | 1 | 2012 | 696 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.070 |
Why?
|
Dobutamine | 1 | 2006 | 123 | 0.070 |
Why?
|
Artifacts | 1 | 2014 | 1904 | 0.070 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.070 |
Why?
|
Fatty Acids | 1 | 2013 | 1809 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 1 | 2012 | 795 | 0.070 |
Why?
|
Odds Ratio | 5 | 2017 | 9849 | 0.070 |
Why?
|
United States | 5 | 2022 | 69872 | 0.070 |
Why?
|
Thoracic Neoplasms | 1 | 2007 | 268 | 0.070 |
Why?
|
Mitochondria | 1 | 2018 | 3514 | 0.070 |
Why?
|
Anesthetics | 1 | 2011 | 539 | 0.070 |
Why?
|
Blood Pressure | 3 | 2011 | 8551 | 0.060 |
Why?
|
Echocardiography, Stress | 1 | 2006 | 131 | 0.060 |
Why?
|
Hematoma | 1 | 2010 | 758 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 7023 | 0.060 |
Why?
|
Anabolic Agents | 1 | 2007 | 247 | 0.060 |
Why?
|
Protein Transport | 1 | 2011 | 1988 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3677 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2013 | 1629 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1416 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25039 | 0.060 |
Why?
|
Gonadal Steroid Hormones | 1 | 2008 | 711 | 0.060 |
Why?
|
Endothelial Cells | 1 | 2017 | 3486 | 0.060 |
Why?
|
Suture Techniques | 1 | 2009 | 798 | 0.060 |
Why?
|
Respiratory Mucosa | 2 | 2008 | 427 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2008 | 934 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7147 | 0.060 |
Why?
|
Cell Membrane | 1 | 2013 | 3749 | 0.060 |
Why?
|
Echocardiography, Four-Dimensional | 2 | 2013 | 16 | 0.060 |
Why?
|
Cell Survival | 1 | 2013 | 5882 | 0.060 |
Why?
|
Tachycardia, Ventricular | 1 | 2012 | 1273 | 0.060 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1423 | 0.060 |
Why?
|
Exercise Test | 1 | 2010 | 2073 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2638 | 0.060 |
Why?
|
Dilatation, Pathologic | 2 | 2014 | 520 | 0.050 |
Why?
|
Steroids | 1 | 2007 | 930 | 0.050 |
Why?
|
Blood Glucose | 2 | 2014 | 6254 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12356 | 0.050 |
Why?
|
Gram-Negative Bacteria | 1 | 2003 | 271 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2013 | 1796 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4925 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2003 | 232 | 0.050 |
Why?
|
Models, Biological | 2 | 2016 | 9584 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2009 | 1739 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1504 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2003 | 362 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2016 | 3922 | 0.050 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2001 | 188 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2010 | 2269 | 0.050 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12244 | 0.050 |
Why?
|
Peritonitis | 1 | 2001 | 365 | 0.040 |
Why?
|
Technology | 1 | 2021 | 304 | 0.040 |
Why?
|
Needles | 1 | 2021 | 449 | 0.040 |
Why?
|
Hemorrhage | 1 | 2010 | 3461 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3154 | 0.040 |
Why?
|
Erythrocyte Transfusion | 1 | 2022 | 565 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10483 | 0.040 |
Why?
|
Escherichia coli Infections | 1 | 2001 | 532 | 0.040 |
Why?
|
Heart Rate | 1 | 2007 | 4092 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2003 | 901 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1897 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2008 | 2400 | 0.030 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.030 |
Why?
|
Hematocrit | 1 | 2017 | 636 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2647 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2003 | 1525 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2887 | 0.030 |
Why?
|
Electrodes | 1 | 2017 | 619 | 0.030 |
Why?
|
Rabbits | 1 | 2001 | 4894 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2005 | 2158 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 816 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2011 | 15160 | 0.030 |
Why?
|
NF-kappa B | 1 | 2003 | 2499 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6582 | 0.030 |
Why?
|
Mice | 3 | 2017 | 81201 | 0.030 |
Why?
|
3T3 Cells | 1 | 2015 | 1101 | 0.030 |
Why?
|
Bioprosthesis | 1 | 2017 | 597 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 547 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2020 | 2453 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 320 | 0.030 |
Why?
|
Epicardial Mapping | 1 | 2012 | 57 | 0.030 |
Why?
|
Signal Transduction | 1 | 2015 | 23404 | 0.030 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2017 | 721 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10388 | 0.030 |
Why?
|
Cost Savings | 1 | 2017 | 925 | 0.030 |
Why?
|
Lipoproteins, LDL | 1 | 2015 | 640 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2003 | 4561 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 354 | 0.020 |
Why?
|
Limb Salvage | 1 | 2013 | 433 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2015 | 783 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1655 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2184 | 0.020 |
Why?
|
Sus scrofa | 1 | 2010 | 437 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2013 | 5316 | 0.020 |
Why?
|
Survival Analysis | 1 | 2001 | 10252 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8319 | 0.020 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2007 | 72 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1578 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 537 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 544 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8300 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1360 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2012 | 964 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2008 | 964 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 7182 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3203 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5388 | 0.020 |
Why?
|
Adrenergic beta-Agonists | 1 | 2006 | 346 | 0.020 |
Why?
|
von Willebrand Factor | 1 | 2008 | 669 | 0.010 |
Why?
|
Health Care Costs | 1 | 2017 | 3208 | 0.010 |
Why?
|
Cathelicidins | 1 | 2003 | 80 | 0.010 |
Why?
|
Anthracenes | 1 | 2003 | 84 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3326 | 0.010 |
Why?
|
Cryopreservation | 1 | 2008 | 670 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4671 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2716 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 964 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2003 | 1157 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2003 | 574 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3922 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2003 | 279 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8091 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 480 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 489 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 452 | 0.010 |
Why?
|
Cell Size | 1 | 2003 | 643 | 0.010 |
Why?
|
Rats | 1 | 2017 | 24252 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.010 |
Why?
|
ROC Curve | 1 | 2008 | 3528 | 0.010 |
Why?
|
Cell Division | 1 | 2008 | 4569 | 0.010 |
Why?
|
Actins | 1 | 2008 | 2121 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 2003 | 675 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21748 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9312 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5101 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1284 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2003 | 1686 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2003 | 1877 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2003 | 1470 | 0.010 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2006 | 1265 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3339 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3873 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2216 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 4459 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3773 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3799 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19233 | 0.010 |
Why?
|
Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
Cell Line | 1 | 2003 | 16000 | 0.010 |
Why?
|
Young Adult | 1 | 2012 | 56429 | 0.000 |
Why?
|